Hypertension: Killing the Silent Killer
- Speaker:
- Sanul Jean Corrielus, MD, MBA, FACC
- Duration:
- 1 Hour
- Format:
- Audio and Video
- Copyright:
-
Dec 12, 2024
- Product Code:
- POS078915
- Media Type:
- Digital Seminar
Description
Join Dr. Sanul Corrielus, a board-certified cardiologist, best-selling author in heart health and CEO of Corrielus Cardiology to address the greatest challenges to manage hypertension. The 2017 ACC/AHA Hypertension Guideline introduced key changes in blood pressure classification and management, lowering the threshold for diagnosing hypertension. Normal blood pressure is now defined as <120/80 mm Hg, while hypertension is classified into elevated (120-129/<80 mm Hg), stage 1 (130-139/80-89 mm Hg), and stage 2 (≥140/90 mm Hg). This has increased the prevalence of hypertension, encouraging earlier detection and intervention. Lifestyle changes are advised for stage 1, but pharmacological treatment is recommended for stage 2 or stage 1 with cardiovascular disease or a 10-year ASCVD risk ≥10%. The guideline sets a blood pressure goal of <130/80 mm Hg for most adults and focuses on specific populations. African Americans at higher risk for complications may require thiazide diuretics or calcium channel blockers. For those with diabetes, tight control of blood pressure is vital to prevent complications, with the same target of <130/80 mm Hg. Older adults should aim for the same goal but with consideration of overall health. Resistant hypertension, where blood pressure remains uncontrolled with three agents, requires further evaluation. Adherence to treatment and lifestyle changes is critical for achieving and maintaining blood pressure control and reducing cardiovascular risks.
Credit
Handouts/Brochure
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - Hypertension: Killing the Silent Killer (12.2 MB) | 51 Pages | Available after Purchase | |
| E-Book - Hypertension: Killing the Silent Killer (385.2 KB) | 51 Pages | Available after Purchase |
Speaker
Sanul Jean Corrielus, MD, MBA, FACC Related seminars and products
Philadelphia Premier Cardiovascular Consultants LLC
Sanul Corrielus, MD, MBA, FACC, is a board-certified cardiologist, best-selling author in heart health and CEO of Corrielus Cardiology. With over two decades of clinical experience, Dr. Corrielus practices preventive cardiology and provides culturally competent care to address health inequities. Corrielus Cardiology offers comprehensive cardiac non-invasive diagnostic evaluations and treatments.
As the founder of the Community Cardiovascular Initiative, Dr. Corrielus promotes heart health education. His approach emphasizes healthcare over sick care, focusing on outreach, education empowerment, and connecting individuals to culturally competent care. Through partnerships with local organizations, health education, and media outreach, he strives to deliver accessible and culturally sensitive care that reflects the community values. Dr. Corrielus encourages people to be active partners in their healthcare.
After completing his internal medicine residency at Temple University Hospital, Dr. Corrielus worked as a primary care provider before entering a cardiovascular fellowship at Howard University Hospital.
Speaker Disclosures:
Financial: Dr. Sanul Corrielus has employment relationships with Allegheny General Hospital and Corrielus Cardiology. He receives a speaking honorarium from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Sanul Corrielus is a member of the National Medical Association, the American Society of echocardiography, the American Society of Nuclear cardiology, and the American College of Cardiology.
Additional Info
Access for Self-Study (Non-Interactive)Access never expires for this product.
For a more detailed outline that includes times or durations of time, if needed, please contact cepepesi.com
Questions?
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Objectives
- Evaluate the salient aspects of 2017 ACC/AHA hypertension guidelines.
- Analyze the new classification of HBP and its impact on prevalence.
- Determine blood pressure thresholds and goals for pharmacological therapy.
- Plan treatment strategies for resistant hypertension.
- Evaluate current hypertension interventions for special populations, including: African Americans, patients with diabetes, and older adults.
Outline
- ACC/AHA HTN guidelines
- Population data and control
- Physiology, pathophysiology, and genetics
- Assessment and diagnosis
- Resistant and secondary hypertension
- Drugs and treatment
- New therapies
Target Audience
- Physicians
- Physician Assistants
- Nurses
Reviews
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...